Document Type
Article
Publication Date
11-24-2023
Abstract
Homologous recombination (HR)-deficiency induces a dependency on DNA polymerase theta (Polθ/Polq)-mediated end joining, and Polθ inhibitors (Polθi) are in development for cancer therapy. BRCA1 and BRCA2 deficient cells are thought to be synthetic lethal with Polθ, but whether distinct HR gene mutations give rise to equivalent Polθ-dependence, and the events that drive lethality, are unclear. In this study, we utilized mouse models with separate Brca1 functional defects to mechanistically define Brca1-Polθ synthetic lethality. Surprisingly, homozygous Brca1 mutant, Polq−/− cells were viable, but grew slowly and had chromosomal instability. Brca1 mutant cells proficient in DNA end resection were significantly more dependent on Polθ for viability; here, treatment with Polθi elevated RPA foci, which persisted through mitosis. In an isogenic system, BRCA1 null cells were defective, but PALB2 and BRCA2 mutant cells exhibited active resection, and consequently stronger sensitivity to Polθi. Thus, DNA end resection is a critical determinant of Polθi sensitivity in HR-deficient cells, and should be considered when selecting patients for clinical studies.
Recommended Citation
Krais, John J.; Glass, David J.; Chudoba, Ilse; Wang, Yifan; Feng, Wanjuan; Simpson, Dennis; Patel, Pooja; Liu, Zemin; Neumann-Domer, Ryan; Betsch, Robert G.; Bernhardy, Andrea J.; Bradbury, Alice M.; Conger, Jason; Yueh, Wei-Ting; Nacson, Joseph; Pomerantz, Richard T.; Gupta, Gaorav P.; Testa, Joseph R.; and Johnson, Neil, "Genetic Separation of BRCA1 Functions Reveal Mutation-Dependent Polθ Vulnerabilities" (2023). Department of Biochemistry and Molecular Biology Faculty Papers. Paper 247.
https://jdc.jefferson.edu/bmpfp/247
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Peer Review File.pdf (498 kB)
Description of Additional Supplementary Files.pdf (113 kB)
41467_2023_43446_MOESM4_ESM.xlsx (14 kB)
Supplementary Data 1
41467_2023_43446_MOESM5_ESM.xlsx (11 kB)
Supplementary Data 2
41467_2023_43446_MOESM6_ESM.xlsx (14 kB)
Supplementary Data 3
Reporting Summary.pdf (2794 kB)
PubMed ID
38001070
Language
English
Comments
This article is the author's final published version in Nature Communications, Volume 14, Issue 1, 2023, Article number 7714.
The published version is available at https://doi.org/10.1038/s41467-023-43446-1. Copyright © The Author(s) 2023.